Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by informatique.ircm
Group name Informatique
Item Type Journal Article
Title TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNF?/TNFR1 signalling regulation in the pathophysiology of TRAPS
Creator Rittore et al.
Author Cécile Rittore
Author Déborah Méchin
Author Elodie Sanchez
Author Léa Marinèche
Author Vuthy Ea
Author Stephan Soler
Author Marion Vereecke
Author Aude Mallavialle
Author Eric Richard
Author Isabelle Duroux-Richard
Author Florence Apparailly
Author Isabelle Touitou
Author Sylvie Grandemange
Abstract Binding of tumour necrosis factor ? (TNF?) to its receptor (TNFR1) is critical for both survival and death cellular pathways. TNF?/TNFR1 signalling is complex and tightly regulated at different levels to control cell fate decisions. Previously, we identified TNFR1-d2, an exon 2-spliced transcript of TNFRSF1A gene encoding TNFR1, whose splicing may be modulated by polymorphisms associated with inflammatory disorders. Here, we investigated the impact of TNFRSF1A variants involved in TNFR-associated periodic syndrome (TRAPS) on TNFR1-d2 protein expression and activity. We found that TNFR1-d2 could be translated by using an internal translation initiation codon and a de novo internal ribosome entry site (IRES), which resulted in a putative TNFR1 isoform lacking its N-terminal region. The kinetic of assembly of TNFR1-d2 clusters at the cell surface was reduced as compared with full-length TNFR1. Although co-localized with the full-length TNFR1, TNFR1-d2 neither activated nuclear factor (NF)-?B signalling, nor interfered with TNFR1-induced NF-?B activation. Translation of TNFR1-d2 carrying the severe p.(Thr79Met) pathogenic variant (also known as T50M) was initiated at the mutated codon, resulting in an elongated extracellular domain, increased speed to form preassembled clusters in absence of TNF?, and constitutive NF-?B activation. Overall, TNFR1-d2 might reflect the complexity of the TNFR1 signalling pathways and could be involved in TRAPS pathophysiology of patients carrying the p.(Thr79Met) disease-causing variant.
Publication Scientific Reports
Volume 11
Issue 1
Pages 4172
Date 2021-02-18
Language en
DOI 10.1038/s41598-021-83539-9
ISSN 2045-2322
URL https://www.nature.com/articles/s41598-021-83539-9
Accessed 2021/03/02 - 12:46:38
Library Catalog www.nature.com
Rights 2021 The Author(s)
Extra Number: 1 Publisher: Nature Publishing Group
Tags top
Date Added 2021/03/02 - 11:46:38
Date Modified 2021/08/26 - 13:47:24
Notes and Attachments Full Text PDF (Attachment)
Snapshot (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés